Mar 08, 2023 / 09:30PM GMT
Operator
Good afternoon. Thank you for attending the Mirum Pharmaceuticals Fourth Quarter and Year-end 2022 Financial Results and Business Update. My name is Matt, and I'll be your moderator for today's call. (Operator Instructions)
I would now like to turn the conference over to our host, Andrew McKibben, Vice President of Investor Relations and Finance. Andrew, please go ahead.
Andrew McKibben -
Thanks, Matt, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals Fourth Quarter and Full Year 2022 Conference Call. I'm joined today by our President and CEO, Chris Peetz, our Chief Operating Officer, Peter Radovich, our Head of R&D, Pam Vig; and our CFO, Ian Clements.
Earlier today, Mirum issued a news release announcing the company's results for the fourth quarter and full year 2022. Copies of this news release and SEC filings can be found in the Investors section of our website. Full details and updates from the quarter can be found in our news release and 10-K issued today.
Before we begin, I'd like to remind you that
Q4 2022 Mirum Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot